'Statin' diaporamas de présentation

Statin - PowerPoint PPT Presentation


Mancini et al, DOI: dx.doi/10.1016/j.cjca.2016.01.003

Mancini et al, DOI: dx.doi/10.1016/j.cjca.2016.01.003

Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).

By Jimmy
(394 views)

Strategies to Better Manage Lipids – Statin Pearls

Strategies to Better Manage Lipids – Statin Pearls

Strategies to Better Manage Lipids – Statin Pearls. Alex Krist MD MPH Family Physician Virginia Commonwealth University Member, US Preventive Services Task Force ahkrist@vcu.edu. Disclaimer.

By lyn
(236 views)

Tara Dall , MD Advanced Lipidology Delafield, Wisconsin

Tara Dall , MD Advanced Lipidology Delafield, Wisconsin

Advances in Statin Therapy: Expert Recommendations for Optimizing the Management of Dyslipidemia in the Clinically Complex Patient. Tara Dall , MD Advanced Lipidology Delafield, Wisconsin Diplomate , American Board of Clinical Lipidology.

By kenyon
(221 views)

Insights from clinical trials : The unassailable case for LDL-c lowering

Insights from clinical trials : The unassailable case for LDL-c lowering

Master class: Exploring the clinical innovations in lipid management? June 4-5, 2010, Barcelona. Insights from clinical trials : The unassailable case for LDL-c lowering. Kausik Ray, MD St Georges University London, United Kingdom. Prof. Kausik Ray: Biography.

By taffy
(102 views)

Diagnostic Evaluation of the Hypertensive Patient- How much is enough?

Diagnostic Evaluation of the Hypertensive Patient- How much is enough?

Diagnostic Evaluation of the Hypertensive Patient- How much is enough?. Thomas Pickering MD, DPhil Behavioral Cardiovascular Health and Hypertension Program Columbia Presbyterian Medical Center New York.

By zev
(90 views)

Difficulty Walking – Reasons for and How to Prevent Falls

Difficulty Walking – Reasons for and How to Prevent Falls

Difficulty Walking – Reasons for and How to Prevent Falls. Michael Sha , MD, FACP Governor, Indiana ACP Chapter Indiana University School of Medicine. 2011 Scientific Meeting Central America ACP Chapter Panama City, Panama. Difficulty Walking. Case:

By redford
(172 views)

Economic evaluation of MRC/BHF Heart Protection Study

Economic evaluation of MRC/BHF Heart Protection Study

Economic evaluation of MRC/BHF Heart Protection Study. Heart Protection Study Collaborative Group University of Oxford UK. HPS: Eligibility criteria. Increased risk of CHD death due to prior disease: Myocardial infarction or other CHD; Occlusive disease of non-coronary arteries; or

By bien
(313 views)

Statin Safety: Key Conclusions and Recommendations of the NLA

Statin Safety: Key Conclusions and Recommendations of the NLA

Statin Safety: Key Conclusions and Recommendations of the NLA. Conclusions of the NLA Safety Task Force for Muscle Safety. Myopathy and rhabdomyolysis are associated with statin therapy, as a class effect Elevated creatine kinase (CK) levels may indicate statin-induced muscle damage

By sinjin
(130 views)

Franciscan St. Anthony Health Michigan City, IN

Franciscan St. Anthony Health Michigan City, IN

Franciscan St. Anthony Health Michigan City, IN. St. Margaret Health. Hammond. St. Anthony Health. Michigan City. 80. 80. 90. 90. St. Anthony Health. Crown Point. 65. St. Francis Health. Indianapolis. 65. Franciscan Health Services, Inc. Franciscan Alliance Corporate Office.

By cynara
(181 views)

Drugs and Labs, what needs to be monitored?

Drugs and Labs, what needs to be monitored?

Drugs and Labs, what needs to be monitored?. Jennifer Rodgers, MSN, ARNP Wichita State University. DRUGS & LABS. We are a testing society Over 1100 tests to pick from RIGHT TEST RIGHT PATIENT Don’t get a test you don’t want the answer too Is the patient willing to participate?.

By eithne
(105 views)

Baseline characteristics of HPS participants by prior diabetes

Baseline characteristics of HPS participants by prior diabetes

Baseline characteristics of HPS participants by prior diabetes. HPS: Baseline lipids (mmol/L) and apolipoproteins (g/L) by prior diabetes. HPS: Baseline lipids (mg/dL) and apolipoproteins (g/L) by prior diabetes. HPS: FACTORIAL TREATMENT COMPARISONS.

By ronni
(107 views)

Lack of Evidence of a Clopidogrel – Statin Interaction in the CHARISMA Trial

Lack of Evidence of a Clopidogrel – Statin Interaction in the CHARISMA Trial

Lack of Evidence of a Clopidogrel – Statin Interaction in the CHARISMA Trial. J Am Coll Cardiol 2007;50:291-5.

By oded
(109 views)

UCLA Comprehensive Atherosclerosis Treatment Program Medication Goals

UCLA Comprehensive Atherosclerosis Treatment Program Medication Goals

Front. Back. UCLA Comprehensive Atherosclerosis Treatment Program Medication Goals All patients with coronary, other vascular disease, or diabetes treated with aspirin and/or clopidogrel*

By zofia
(105 views)

Clinical Biochemistry

Clinical Biochemistry

Clinical Biochemistry. FAQ for GP Trainees. Dr Mourad Labib Consultant Chemical Pathologist DGOH NHS Foundation Trust. July 2009. Common scenarios How best to investigate common problems Gold Standard investigations Advances in Clinical Biochemistry. Plan.

By zenda
(259 views)

STATINS ANTI-CHOLESTEROL AGENTS

STATINS ANTI-CHOLESTEROL AGENTS

Patrick: An Introduction to Medicinal Chemistry 4e. Case Study 1. STATINS ANTI-CHOLESTEROL AGENTS. 1. Cholesterol. Notes Important in biosynthesis and cell membrane structure Excess cholesterol leads to cardiovascular disease

By coby
(400 views)

Factors That Increase the Risk of Myopathy in People Taking Statins

Factors That Increase the Risk of Myopathy in People Taking Statins

Factors That Increase the Risk of Myopathy in People Taking Statins. 5) Jones PH, Davidson MH. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol. 2005; 95: 120–122.

By nansen
(76 views)

THE ABC’S OF THE AHA/ACC Ischemic Heart Disease GUIDELINES Roger S. Blumenthal, MD

THE ABC’S OF THE AHA/ACC Ischemic Heart Disease GUIDELINES Roger S. Blumenthal, MD

THE ABC’S OF THE AHA/ACC Ischemic Heart Disease GUIDELINES Roger S. Blumenthal, MD Professor of Medicine Director, The Johns Hopkins Ciccarone Center For The Prevention of Heart Disease. DEFINITION.

By nhi
(197 views)

The New Lipid Guidelines

The New Lipid Guidelines

The New Lipid Guidelines. What you need to know Paul J Kovack, DO, FACOI, FACC. Overview. NHLBI ACC/AHA First new guidelines since ATP III guideline update in 2004 Review the most important statements or changes presented in these guidelines No longer have therapeutic targets

By sarah
(655 views)

CM Ballantyne, 1 JS Raichlen, 2 SJ Nicholls, 3 R Erbel, 4

CM Ballantyne, 1 JS Raichlen, 2 SJ Nicholls, 3 R Erbel, 4

Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID. CM Ballantyne, 1 JS Raichlen, 2 SJ Nicholls, 3 R Erbel, 4 J-C Tardif, 5 SJ Brener, 3 VA Cain, 2 SE Nissen, 3 For the ASTEROID Investigators.

By swann
(126 views)

Restless leg, Cardiology

Restless leg, Cardiology

Restless leg, Cardiology. Which of the following agents is associated with exacerbations of restless legs syndrome (RLS)?  A) Diphenhydramine  B) Iron  C) Zolpidem  D) Gabapentin. Answer. A) Diphenhydramine.

By meir
(188 views)

View Statin PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Statin PowerPoint presentations. You can view or download Statin presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.